Earn CME credit for this activity: https://www.naccme.com/program/2018-802-05
This on-demand webcast examines recent clinical trial data for novel and emerging therapies, including doublet and triplet combinations for relapsed/refractory disease, and discusses how best to integrate recent therapeutic advances into clinical pathways.
© 2018 NACCME, an HMP Company
Advertisement